NTCOC
ARNA

Northern Trust Company of Connecticut’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-6,564
Closed -$505K – 2015
2013
Q2 		$505K Buy
+6,564
New +$536K ﹤0.01% 1483

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Northern Trust Company of Connecticut's ARNA Position: Q3 2013 in Review

Northern Trust Company of Connecticut sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2013, closing a stake of 6,564 shares — an estimated $505K sold.

Northern Trust Company of Connecticut first reported a position in ARNA in Q2 2013 and held it in 1 quarter. The position peaked at $505K in Q2 2013. 140 funds tracked by Wall St. Rank hold ARNA as of Q3 2013.

  • Northern Trust Company of Connecticut reported no remaining Arena Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • Northern Trust Company of Connecticut sold 6,564 Arena Pharmaceuticals Inc shares in Q3 2013, an estimated $505K.
  • Northern Trust Company of Connecticut first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • Northern Trust Company of Connecticut's Arena Pharmaceuticals Inc position peaked at $505K in Q2 2013.
  • 140 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q3 2013, filed 13 Nov 2013.